PharmaCyte Biotech, Inc. (PMCB)
0.3422
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
0.3411
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech EPS Diluted (Quarterly) : -0.5389 for July 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.5389 |
| April 30, 2026 | -0.454 |
| January 31, 2026 | -0.168 |
| October 31, 2025 | -1.238 |
| July 31, 2025 | -1.230 |
| April 30, 2025 | 1.596 |
| January 31, 2025 | -0.4376 |
| October 31, 2024 | -0.3874 |
| July 31, 2024 | 1.901 |
| April 30, 2024 | -0.3161 |
| January 31, 2024 | -0.653 |
| October 31, 2023 | -0.2576 |
| July 31, 2023 | -0.5376 |
| April 30, 2023 | -0.0075 |
| January 31, 2023 | -0.0402 |
| October 31, 2022 | -0.0914 |
| July 31, 2022 | -0.0742 |
| April 30, 2022 | -0.8947 |
| January 31, 2022 | -0.0374 |
| October 31, 2021 | -0.0564 |
| July 31, 2021 | -0.6444 |
| April 30, 2021 | -0.615 |
| January 31, 2021 | -0.48 |
| October 31, 2020 | -0.615 |
| July 31, 2020 | -0.795 |
| Date | Value |
|---|---|
| April 30, 2020 | -0.69 |
| January 31, 2020 | -0.96 |
| October 31, 2019 | -1.215 |
| July 31, 2019 | -1.41 |
| April 30, 2019 | -1.50 |
| January 31, 2019 | -0.90 |
| October 31, 2018 | -1.44 |
| July 31, 2018 | -1.74 |
| April 30, 2018 | -1.92 |
| January 31, 2018 | -3.12 |
| October 31, 2017 | -2.79 |
| July 31, 2017 | -2.73 |
| April 30, 2017 | -1.92 |
| January 31, 2017 | -2.235 |
| October 31, 2016 | -1.725 |
| July 31, 2016 | -1.965 |
| April 30, 2016 | -2.16 |
| January 31, 2016 | -3.555 |
| October 31, 2015 | -3.285 |
| July 31, 2015 | -3.075 |
| April 30, 2015 | -5.775 |
| January 31, 2015 | -3.135 |
| October 31, 2014 | -15.00 |
| July 31, 2014 | -3.39 |
| April 30, 2014 | -35.78 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.081M |
| Total Expenses (Quarterly) | 5.081M |
| Enterprise Value | -24.95M |
| Earnings Yield | -701.2% |
| Normalized Earnings Yield | -368.99 |